The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  There have been some ground-breaking advances in women’s health this week, with new treatments for hot flushes and pregnancy sickness, and a discovery that could aid in development of treatments for secondary breast cancer. In other news, the FDA approved a promising antibody-drug conjugate for bladder cancer and trial results demonstrated that psilocybin could reduce depression symptoms in cancer patients. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The podcast covers the latest innovation in neuroscience, including a differentiated approach to developing therapeutics for neurodegenerative diseases, the potential of digital biomarkers to improve drug development, and efforts to enhance technologies for neuroscientists.

This podcast highlights key stories from the drug discovery world, focusing on haematology. Topics include real-world evidence on CAR-T therapies in blood cancers, new data for myeloma and lymphoma treatments, clinical trial results for lymphoma and pediatric acute lymphoblastic leukemia therapies, and a collaboration for manufacturing lentiviral vectors for CAR-P-A-L-L clinical trial.

The latest sponsored DDW Sitting Down With podcast features Charles Powell, CEO of Aurora Microplates, discussing how the microplate has evolved to keep up with changing trends within research and development. The microplate is a seemingly simple tool, yet it has a crucial role to play in ensuring accurate data throughout the drug discovery process. Powell will explain how the materials and manufacturing process of a microplate can impact chemical reactions in the lab and ultimately define the consistency of the scientific results. Listen now.

This podcast highlights new developments in neuroscience, including a drug repurposing fund and a drug target for early-onset dementia. It also mentions a potentially game-changing schizophrenia drug entering human trials. Additionally, the podcast discusses a collaboration agreement for schizophrenia and osteoarthritis research, new insights on osteoarthritis treatment, and a study on lineogen's effects on platinum resistant ovarian cancer.

Experimental approaches to treat challenging diseases: mathematical model simulating Alzheimer's progression, CRISPR gene editing 'shredding' tumours; Potential therapeutic advances in Parkinson's Disease and Multiple Sclerosis; Revolutionizing drug development with cyclic proteins and peptides; Mathematical modeling for personalized Alzheimer's treatments; Using CRISPR to target recurrent glioblastoma and hyper-mutated tumors.

Explore the latest research on synthetic microbiomes, drug repurposing, and muco-adhesive drug delivery. Learn about the potential of microbiome therapies, the benefits and challenges of drug repurposing, advancements in clinical data availability, and the potential of muco-adhesive drug delivery systems. Discover how these innovative approaches are shaping the future of drug discovery.

This podcast explores the post-COVID industry landscape, legal challenges faced by Moderna and BioNTech SE, the use of AI in streamlining drug discovery, challenges in AI for drug discovery and data privacy laws, and the evolving relationship between biotech and AI companies in drug discovery.

This podcast highlights the first regulatory approval for Casgevy, a gene therapy using CRISPR gene editing for sickle cell disease. Other breakthroughs in cell and gene therapy are discussed, including Verve 101 for cardiovascular disease, Axicab2Gin Silo-Lucial for lymphoma, Cascavii for sickle cell disease and beta thalassemia, AB 1002 for advanced heart failure, and global collaboration for CAR-T DDBCMA.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  With the first DDW Turning Science into Business Summit taking place next week on the theme of Cancer Research, this dynamic area of drug discovery is this week's round-up focus again. Most significantly, this week has seen the UK approval of a new indication for anastrozole in the prevention of breast cancer and a number of significant findings in the field of immunotherapy announced at SITC 2023. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.